top of page
Nelson Advisors > European Healthcare Technology Investment Banking


PitchFest Awards at Digital Health ReWired 2026: Nelson Advisors invited to the Judges Panel
Nelson Advisors Partner Lloyd Price has been invited to Judge the PitchFest Awards at ReWired 2026. This is the third time Lloyd has judged the prestigious awards, highlighting the pedigree of UK Digital Health and MedTech companies. Unlike standard "demo days," PitchFest is specifically designed to break down the barriers between start-ups and the NHS. The judges are not just venture capitalists but also Chief Information Officers (CIOs) and Chief Clinical Information Office
Nelson Advisors
Dec 9, 2025


Nelson Advisors invited to Chair the 'Health Data Under Attack' Panel at Health Tech Forward 2025 in Barcelona
Nelson Advisors invited to Chair the 'Health Data Under Attack: Emerging Vulnerabilities in Healthcare' Panel at Health Tech Forward 2025 Nelson Advisors Partner Lloyd Price Chaired the 'Health Data Under Attack: Emerging Vulnerabilities in Healthcare panel' at Health Tech Forward 2025 in Barcelona this week. The panel focused around 5 main questions debated by the guests Laura, Alberto and Naoufal. 1) Laura Busquet Raich, Head of Data Protection and ComplianceConsorci de Sa
Nelson Advisors
Dec 9, 2025


Nelson Advisors invited to Chair the 'Finance in Healthcare’ Panel at the IESE Business School Healthcare Club event
Nelson Advisors Partner Lloyd Price was invited to Chair the discussions at the IESE Business School Healthcare Club event on the 3rd December in Barcelona. Lloyd was joined on the panel by Javier Matacàs, Investment Director at Careventures and Ilan Misano, CEO of X-Applied and former Head of the StartUp Growth Lab - Google Israel's startup accelerator.
Nelson Advisors
Dec 9, 2025


Nelson Advisors invited to join the MedTech Innovator 2026 Programme as a Judge and MedTech Mentor
Nelson Advisors has been invited to mentor and judge the MedTech Innovator 2026 programme alongside a panel of esteemed US and European industry executives. Now in its 13th year, MedTech Innovator, the world’s largest medtech accelerator continues to identify the most promising medical device, diagnostic, and digital health startups developing innovative tools to improve patient care.
Nelson Advisors
Dec 3, 2025


European HealthTech and MedTech M&A Predictions for 2026
The European HealthTech and MedTech M&A landscape in 2026 is poised for significant strategic acceleration, marking a transition from cautious, volume-driven dealmaking to high-value, transformative transactions. Deal flow is consolidating toward fewer but substantially larger deals, with market participants prioritising scalable technologies with robust clinical validation and AI integration capabilities.
Nelson Advisors
Dec 2, 2025


Nelson Advisors featured in Forbes: 5 High-Growth Business Models Set To Thrive In The Coming Decade
Nelson Advisors thought leadership has been referenced in the Forbes article '5 High-Growth Business Models Set To Thrive In The Coming Decade' outlining five business models that are primed for success in the coming years.
Nelson Advisors
Oct 10, 2025


This Week in European HealthTech and MedTech: 5th October 2025
The major stories in the world of European MedTech this week are dominated by regulatory activity under the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), a significant European Commission "Call for Evidence" for future reforms, and fresh funding for companies focused on connected and remote monitoring devices.
Nelson Advisors
Oct 5, 2025


The German Digital Health Act (DiGA): Strategy, Impact, Challenges and Future Direction
The German Digital Health Act (DiGA), a foundational element of Germany's broader digital healthcare transformation, represents a pioneering legislative initiative to integrate digital health applications into mainstream medical care. Initiated by the Digital Healthcare Act (DVG) in 2019 and further bolstered by the Digital Act (DigiG) in 2024, this framework enables "apps on prescription" to be reimbursed by statutory health insurers, covering approximately 90% of the German
Nelson Advisors
Jul 19, 2025
bottom of page